RnRMarketResearch.com adds “Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015” to its store. This report provides elemental information and data relating to the clinical trials on Non Alcoholic Fatty Liver Disease (NAFLD)

Non-alcoholic fatty liver disease (NAFLD) describes a range of conditions caused by a build-up of fat within liver cells. It is very common and in many cases is linked to being obese or overweight. In some people, the build-up of fat in the liver can lead to serious liver disease. The main treatment advised for NAFLD is usually gradual weight loss and regular exercise. NAFLD may cause the liver to swell. A swollen liver may cause scarring (cirrhosis) over time and may even lead to liver cancer or liver failure. When symptoms occur, they may include fatigue, weakness, weight loss, loss of appetite, nausea, abdominal pain, spider-like blood vessels, yellowing of the skin and eyes (jaundice), itching, fluid buildup and swelling of the legs (edema) and abdomen (ascites), and mental confusion. Eating a healthy diet and exercising regularly may help prevent liver damage from starting or reverse it in the early stages.

GlobalData’s clinical trial report, “Non Alcoholic Fatty Liver Disease (NAFLD) Global Clinical Trials Review, H1, 2015″ provides data on the Non Alcoholic Fatty Liver Disease (NAFLD) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Non Alcoholic Fatty Liver Disease (NAFLD). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Non Alcoholic Fatty Liver Disease (NAFLD). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note:-Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Complete Report is Available at http://www.rnrmarketresearch.com/non-alcoholic-fatty-liver-disease-nafld-global-clinical-trials-review-h1-2015-market-report.html                                         

Scope:

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type.
• Listings of discontinued trials (suspended, withdrawn and terminated)

Order a Purchase copy of this report at http://www.rnrmarketresearch.com/contacts/purchase?rname=276883 . (This is a premium report priced at US$2000 for a single user License.)

Reasons to Buy:

• Understand the dynamics of a particular indication in a condensed manner.
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more.
• Obtain discontinued trial listing for trials across the globe.
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies.

Explore more reports on Pharmaceuticals at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals .

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.